Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-13

FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (CVS PHARMACY, INC)

View source ↗

Summary

FDA approved a supplemental application for CVS Pharmacy, Inc.'s Arthritis Pain Reliever diclofenac sodium product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arthritis Pain Reliever (Diclofenac sodium)

Snippet

SUPPL AP for ARTHRITIS PAIN RELIEVER (DICLOFENAC SODIUM)